Pfizer, Starboard Value and Bloomberg
Pfizer avoids board nominations from Starboard as proxy fight rolls on: Bloomberg
Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the activist investor’s unfolding proxy fight. | Activist Investor Starboard Value stopped short of nominating any directors to Pfizer’s board ahead of a Jan.
5don MSN
Average Cost: $70.92 Activist Commentary: Starboard is a very successful activist investor and has extensive experience ...
Bitcoin miner Riot Platforms (RIOT) finds itself a target of a second activist investor, with Reuters reporting investment ...
GlobalData on MSN10d
Starboard Value acquires 7.7% stake in chipmaker QorvoActivist investor Starboard Value has acquired a 7.7% stake in Qorvo, a NASDAQ-listed maker of radio frequency and power ...
D.E. Shaw’s stake in Riot Platforms, alongside Starboard’s involvement, signals potential changes for the Bitcoin mining giant.
Qorvo shares jumped 11% Friday when hedge fund Starboard Value made a significant investment in the maker of radio ...
D.E. Shaw has followed Starboard Value in building up a stake in Bitcoin miner Riot Platforms to push the company to make ...
Investment firm D.E. Shaw has built a position in Riot Platforms and may push it to make changes, two sources familiar with ...
Starboard last year took a $1 billion stake in Pfizer, looking to turn the pharma around after alleged severe shortcomings by ...
Shares of communications chips maker Qorvo (NASDAQ: QRVO) jumped 11.9% in the morning session after activist investor, ...
Qorvo (QRVO) shares fell 0.5% in premarket trading on Friday, even as Mizuho Securities upped its earnings estimates on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback